<DOC>
	<DOCNO>NCT00277108</DOCNO>
	<brief_summary>The purpose study determine Escitalopram ( Lexapro ) effective treatment postpartum depression .</brief_summary>
	<brief_title>Lexapro Treatment Patients With Postpartum Depression</brief_title>
	<detailed_description>Primary objective : Remission Major Depression : To determine efficacy flexibly titrate dose Escitalopram ( 10mg 20 mg ) treatment woman postpartum depression . The primary outcome measure remission major depression , define score 12 less Montgomery-Asberg Depression Scale . A score 7 less Hamilton Depression Scale ( 21 item ) use secondary measure remission . The null hypothesis flexibly dose Escitalopram lead remission major depression base total MADRS score 8 week treatment . Secondary objective : 1 . To determine treatment Escitalopram effective achieve significant reduction symptom postpartum depression measure several instrument : HAM-D 21 , CGI , Beck Depression Inventory , Edinburgh Postnatal Depression Scale . Specifically , response define reduction total score 50 % baseline MADRS HAM-D 21 . 2 . To determine tolerability , safety dose consideration Escitalopram special subpopulation depress patient . Adverse event data ( clinical laboratory ) , compliance early termination use outcome measure . 3 . To determine post-hoc analysis pre-study anxiety level measure HAM-A correlate primary secondary outcome .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Biological mother infant age 2 week 12 month age 2 . Age 18 3 . Must understand speak English well enough read provide write informed consent , complete write questionnaires complete SCID . 4 . The primary Axis I diagnosis , determine SCID , must meet DSMIV criterion Unipolar Major Depression , Single Recurrent , Moderate Severe . Onset depression must occur within pregnancy first 12 month follow childbirth . Concurrent diagnosis anxiety disorder include obsessive compulsive disorder , panic disorder , specific phobia , generalize anxiety disorder , posttraumatic stress disorder allow primary diagnosis . 5 . The subject must receive MADRS total score &gt; 22 screen baseline visit total score &gt; 17 HAMD baseline visit . 6 . The subject must able comply instruction capable participate 8 week study . 1 . Under 18 year age . 2 . Subjects breastfeed . 3 . History Bipolar Disorder , Schizoaffective Disorder , Schizophrenia . 4 . History DSMIV Axis II diagnosis , investigator 's opinion , would interfere compliance protocol . 5 . History alcohol drug abuse dependence last year . 6 . Treatment psychotropic drug except permissible concomitant . 7 . Current severe psychiatric symptom require psychiatric hospitalization , current psychosis suicidal , homicidal potential . 8 . History intolerance hypersensitivity Citalopram . 9 . Subjects whose depression know unresponsive Escitalopram . 10 . Subjects pregnant intend become pregnant course study . 11 . Subjects medical neurological disorder investigator ' opinion may contribute depression . 12 . Subjects start psychotherapy within three month prior baseline intend start psychotherapy study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>postpartum depression</keyword>
	<keyword>postnatal depression</keyword>
	<keyword>PPD</keyword>
</DOC>